Hester Biosciences Limited through its Veterinary Social Business (VSB) division has recently launched a new initiative to support animal product technology to improve profitability for livestock entrepreneurs. The Livestock and Veterinary Entrepreneurship Development (LiVE) initiative aims to increase awareness of low-cost inputs such as silage and hay making, feed blocks and mineral blocks, as well […]

Last year, Dr Carolin Schumacher joined our team as the new Chief Executive. She recently sat down with industry magazine Animal Pharm to talk about her aspirations and  how she is steering GALVmed towards providing better livestock health services to smallholder farmers. Read more on this insightful interview.  

To commemorate the 2019 World Veterinary Day whose theme was the Value of Vaccination, the Veterinary Social Business (VSB) division of Hester Biosciences Limited, a GALVmed partner in South Asia, recently conducted a weeklong livestock vaccination campaign. The seven-day campaign was an innovative awareness activity on the value of livestock vaccination. The campaign targeted all […]

Inaugural scientific workshop held from 19-20 March 2019 in Nairobi, Kenya During the Keystone Symposia in Cape Town (2016) African scientists set the base for establishing the African Vaccinology Network (AfVANET) as a forum for African scientists to take greater part in establishing priorities for vaccine development for emerging and re-emerging human and veterinary diseases […]

Warm greetings and best wishes for a successful and prosperous 2019! While the New Year is still young, I would like to share with you some of the key moments for GALVmed in 2018 and update you on our plans for 2019. 2018 was a year rich in events at GALVmed. It marked the start […]

GALVmed, with its partner Hester Bioscience Limited has signed a new Memorandum of Understanding (MoU) with Bihar Rural Livelihoods Promotion Society (BRLPS) to accelerate vaccination of livestock against Peste des Petit Ruminants (PPR) and Newcastle Disease in the State of Bihar, India. GALVmed and Hester are currently working to develop a reliable and sustainable supply […]

It is a great honour and pleasure for me to have been appointed as the new CEO of GALVmed. I join the organisation at a moment where GALVmed can look back proudly onto 10 years of successful operations and has established a solid foundation of experienced staff, strong partners and good funding. Let us stop […]

GALVmed has received funding approval totalling to US$ 19 million for the Phase 3 programme on Improved Tools for the Control of Animal African Trypanosomosis (Tryps 3). The main objective of the programme, which is co-funded by the UK Government and Bill & Melinda Gates Foundation, is to commercially develop a registered therapeutic trypanocidal product […]

In September 2018 Dr Peter Wells retired from GALVmed’s Board of Trustees. Peter became involved with GALVmed initially through the Expert Scientific Advisory Committee before involvement in the governance of GALVmed early 2011. After a brief period as interim CEO Peter was formally appointed as a trustee in April 2012. During his time as trustee […]

GALVmed representatives Jeremy Salt and Mark Rweyemamu are this week attending a meeting in Vienna, Austria, to launch the Peste des petits ruminants Global Research and Expertise Network (PPR-GREN). The PPR-GREN network was established and endorsed in 2015 to support a global strategy to eradicate PPR. Peste des petits ruminants,or simply known as PPR, was […]